


180 Life Sciences Revenue
Biotechnology Research • • 1-10 Employees
180 Life Sciences revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | $3,000,000 |
Key Contact at 180 Life Sciences
Jonathan Rothbard
Founder and Chief Scientific Officer 180 Life Sciences
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About 180 Life Sciences
180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
180 Life Sciences has 1 employees across 1 departments.
Departments
Number of employees
180 Life Sciences Tech Stack
Discover the technologies and tools that power 180 Life Sciences's digital infrastructure, from frameworks to analytics platforms.
Video players
JavaScript libraries
CDN
Web servers
JavaScript libraries
Programming languages
Blogs
Analytics
UI frameworks
SEO
Tag managers
Frequently asked questions
4.8
40,000 users



